Invo BioScience (INVO)
(Delayed Data from NSDQ)
$1.17 USD
-0.13 (-10.00%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.07 -0.10 (-8.55%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Invo BioScience Inc. [INVO]
Reports for Purchase
Showing records 1 - 18 ( 18 total )
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
4Q20 Recap - Momentum Building for INVO-Owned Centers
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
Company: Invo BioScience Inc.
Industry: Medical - Biomedical and Genetics
We launch coverage with a Buy rating and a $5.75/share price target
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
|